The Non-Financial Ledger: What a $2,500 Fine Cannot Measure

Think about the spring of 2020. Schools closed. Hospitals ran out of gowns. People wiped down their groceries with bleach wipes. Millions of families were terrified of surfaces, of air, of each other. In that moment of mass fear and scientific uncertainty, people were desperate for anything that felt like protection.

That is the environment in which PreVasive chose to advertise OXYdiff. The company did not slip up and use vague language. The claim was specific and deliberate: COVID-19 is caused by SARS-CoV-2, OXYdiff kills “similar viruses,” therefore OXYdiff “can be used against Sars-CoV-2.” It directed users to follow the instructions for Canine Parvovirus on hard surfaces. Canine Parvovirus. That is the comparison the company chose to invoke while people were dying in ventilator shortages.

The person who bought OXYdiff did not receive an EPA-tested, EPA-registered, label-verified disinfectant. They received a product whose mixing instructions, printed on its own Safety Data Sheet, did not even match the registered base product. The ratio. The dilution. The activation steps. All different from what the EPA had actually reviewed and approved. The product was, in the eyes of federal law, unregistered. The person using it on their kitchen counter, their daycare’s doorknobs, their elderly parent’s bathroom, had no way to know that.

There is a reason the EPA registration process exists. It is not bureaucratic box-checking. A registered pesticide has had its efficacy claims tested. Its label has been reviewed so that a real person in a real building can follow the directions and actually kill what the label says it kills. When a company invents claims that do not appear on the approved label, it destroys that entire chain of assurance. The person following PreVasive’s instructions was not following EPA-reviewed instructions. They were following whatever PreVasive decided to print.

The second product, PreVasive BHP Industrial Strength, was sold on the basis of “proprietary Nano-Zinc antimicrobial technology.” Antimicrobial. That word carries weight in the mind of a buyer. It implies science. It implies testing. It implies that something is actually being killed. PreVasive had no EPA registration to back that implication up. None. The product did not exist in the EPA’s Pesticide Product Labeling System. It was, by every applicable definition, illegal to sell.

The fine is $2,500. No criminal charges are mentioned in the source material. No product recall is documented. The company certified it is now in compliance, neither admitted nor denied the facts, waived its right to contest, and will pay less than the cost of a used car to close the book on selling unregistered pesticides with COVID-19 kill claims. The people who bought OXYdiff believing it could protect them from a virus that killed millions of people globally will never see a refund, a notice, or an apology.

Legal Receipts: What the EPA Actually Found, in Their Own Words

Every quote below is transcribed verbatim from EPA Consent Agreement and Final Order, Docket No. FIFRA-04-2025-3012(b), signed December 22, 2025. PreVasive neither admitted nor denied these factual findings but waived all rights to contest them.

Societal Impact Mapping: Who Gets Hurt When Pesticide Enforcement Has No Teeth

Public Health

Unregistered pesticides with fabricated kill claims pose direct and measurable public health risks. The harm is not hypothetical.

• Consumers who purchased OXYdiff based on its COVID-19 claim may have relied on it as a primary disinfection measure against SARS-CoV-2. The EPA never verified that OXYdiff, mixed according to its own SDS instructions, is effective against any virus. A person who believed they were protected and was not is at direct risk.
• The Safety Data Sheet for OXYdiff contained mixing instructions that diverged from the registered product’s label. Chemical products mixed at incorrect concentrations can be ineffective, and in some cases produce harmful residues or fail to neutralize pathogens entirely. Anyone following PreVasive’s activation instructions rather than HyCide’s approved instructions was operating without a tested safety margin.
• The COVID-19 framing in PreVasive’s marketing was particularly predatory during a period of elevated public health anxiety. Vulnerable populations, including the elderly, immunocompromised individuals, and caregivers in institutional settings, are the most likely buyers of commercial-grade disinfectants claiming pathogen efficacy. Those populations bear the greatest consequence when those claims are fraudulent.
• PreVasive BHP Industrial Strength’s “Nano-Zinc antimicrobial technology” claim, attached to a product with zero EPA registration, means buyers had no independently validated evidence that the product inhibited microbial growth at all. Any facility relying on this product for microbial surface protection received no regulatory assurance of its effectiveness.
• The EPA registration system serves as a national quality floor for pesticidal products. Each unregistered product that reaches consumers without EPA review degrades public confidence in legitimate registered disinfectants and creates market pressure on compliant manufacturers to compete with fraudulent claims.

Economic Inequality

The structure of this penalty reinforces an existing pattern: small fines for corporate violations of public health law do not deter repeat conduct, and the cost of that non-deterrence falls heaviest on people with the fewest resources to absorb it.

• A $2,500 fine for selling unregistered pesticides with COVID-19 kill claims is, by any reasonable business calculus, cheaper than EPA registration itself. The EPA registration process involves fees, testing, label review, and ongoing compliance costs. A company that can avoid all of that and settle a federal enforcement action for $2,500 has been handed a cheaper path to market.
• Consumers who purchased these products spent real money on the belief that they were buying EPA-backed protection. That money is gone. The settlement does not include any consumer restitution mechanism visible in the source material. Buyers are left with no remedy.
• Legitimate cleaning and disinfectant product manufacturers who go through the full EPA registration process bear compliance costs that PreVasive avoided. The $2,500 settlement does not correct the economic distortion created by years of competing with unregistered products carrying false efficacy claims.
• Small businesses and low-income households operating on tight cleaning supply budgets are more likely to purchase products based on strong marketing claims and lower price points. These buyers have less capacity to independently verify EPA registration status and are therefore more exposed to harm from products like those PreVasive sold.
• The consent agreement explicitly notes it was calculated in part based on PreVasive’s “substantiated ability to pay claim,” meaning the company demonstrated financial hardship and the fine was reduced accordingly. The people who bought these products had no equivalent mechanism to reduce the harm they absorbed.

The “Cost of a Life” Metric: What $2,500 Actually Means

The EPA calculated PreVasive’s penalty after considering the company’s “substantiated ability to pay claim.” Here is what that fine looks like in human scale.

What Now: The People Responsible, the Watchlist, and What You Can Do

PreVasive USA, LLC remains a company operating in Oakwood, Georgia. The consent agreement states that violations have been corrected and the company is currently in compliance. Here is who is accountable and where to apply pressure.

Corporate Leadership on Record

• Brian Brosdahl, Chief Executive Officer, PreVasive USA, LLC. Brosdahl is named in the Certificate of Service as the direct recipient of the enforcement action and is the signatory representing the company. Email on record: brian@prevasive.com.
• Graham McKinnon, Partner, Fox, Chandler, Homans, Hicks & McKinnon, LLP. Legal counsel of record for PreVasive in this proceeding. Firm location: Gainesville area, Georgia.

Regulatory Watchlist

• EPA Region 4, Enforcement and Compliance Assurance Division: The office that brought this action. Director Keriema Newman signed off on the consent agreement. Any future violations by PreVasive would be handled here first. Contact: R4_Regional_Hearing_Clerk@epa.gov.
• EPA Office of Pesticide Programs (OPP): The national office responsible for maintaining the Pesticide Product Labeling System. You can verify whether any pesticide product is registered by searching the OPP’s public database at epa.gov/pesticide-registration.
• Federal Trade Commission (FTC): The FTC has authority over deceptive advertising claims, including health and efficacy claims on consumer products. COVID-19-related false marketing claims were a documented FTC enforcement priority during the pandemic. If you encountered PreVasive’s COVID-19 marketing, the FTC accepts consumer complaints at reportfraud.ftc.gov.
• Georgia Department of Agriculture, Pesticide Division: State-level pesticide enforcement in Georgia operates independently of EPA Region 4. State agencies can pursue parallel action under Georgia’s own pesticide statutes.
• U.S. Department of Justice: FIFRA Section 14(b) authorizes criminal sanctions for knowing violations. The DOJ is the referral target if EPA determines a civil penalty is insufficient. The consent agreement preserves EPA’s right to refer criminal matters.

What You Can Do Right Now

• Check before you buy. Before purchasing any cleaning or disinfectant product that claims to kill viruses, bacteria, mold, or other microorganisms, verify it in the EPA’s official Pesticide Product Labeling System. The search is free and takes under a minute. A product not in that database is illegal to sell as a pesticide in the United States.
• Report suspected unregistered pesticides. If you find a product on a retail website, physical store shelf, or online marketplace making antimicrobial, disinfectant, or pest-kill claims without a visible EPA registration number, report it to the EPA at epa.gov/tips or call the EPA’s Region 4 office directly.
• Push for stronger penalties at the federal level. The $2,500 fine in this case reflects FIFRA’s penalty structure adjusted for inflation and ability to pay. Advocacy organizations focused on consumer protection and environmental health, including groups like Earthjustice, Public Citizen, and the Center for Biological Diversity, actively lobby for increased civil penalty caps under FIFRA. Supporting those organizations puts pressure on Congress to raise the floor.
• Organize locally around pandemic-era fraud. Many communities were targeted by fake disinfectant and PPE schemes during COVID-19. Local mutual aid networks can circulate verified EPA product lists, host community verification workshops, and connect affected buyers with consumer protection attorneys who handle false advertising claims. The harm was community-scale; the response should be too.
• Demand transparency on future PreVasive compliance. The consent agreement is a public document. PreVasive is now on record with a federal enforcement history. Any future FIFRA enforcement against PreVasive must consider this CAFO as prior compliance history under the terms of the agreement. Stay on it.